Recent advances in gene therapy-based cancer monotherapy and synergistic bimodal therapy using upconversion nanoparticles: Structural and biological aspects
In accordance with human genetics and genomics advances over the past years, it can be found that cancer is created through a somatic aberration in the host genome. Accordingly, researchers use therapeutic methods in genetic manipulation to discover the possible cure for the disease. In combination...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-12-01
|
| Series: | Biomedicine & Pharmacotherapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222012616 |
| _version_ | 1811180165326176256 |
|---|---|
| author | Marzieh Sohrabi Zahra Babaei Vahid Haghpanah Bagher Larijani Ali Abbasi Mohammad Mahdavi |
| author_facet | Marzieh Sohrabi Zahra Babaei Vahid Haghpanah Bagher Larijani Ali Abbasi Mohammad Mahdavi |
| author_sort | Marzieh Sohrabi |
| collection | DOAJ |
| description | In accordance with human genetics and genomics advances over the past years, it can be found that cancer is created through a somatic aberration in the host genome. Accordingly, researchers use therapeutic methods in genetic manipulation to discover the possible cure for the disease. In combination with traditional cancer treatments, gene therapy (GT) is essential in future cancer therapy. The development of powerful nanocarriers for targeted, controlled, and efficient intracellular delivery of therapeutic biomolecules that increase pharmacokinetics indicates that the development of GT is highly dependent on nanotechnology. Among nanocarriers, upconversion nanoparticles (UCNPs) have become the focus of great attention in the realm of inorganic nanomedicines following the strategy of ''diagnosis for treatment'' due to their outstanding features including safety, deep penetration of near-infrared (NIR) light into tissue, and reduction of unfavorable side effects of NIR-triggered therapies. Moreover, various individual therapies can be intelligently combined into a single nanotranostic system based on a UCNP platform for multimodal synergistic treatment. Given that the preparation of multifunctional nanomaterials is a prerequisite for the realization of cancer treatment, especially synergistic therapies, the recognition of the main components of advanced nanoparticles can help researchers in choosing the proper platform for cancer treatment. In view of this, the main goal of this review is to highlight the latest advances in the construction and application of upconversion nanoparticles as carriers for gene delivery and gene editing in cancer monotherapy and bimodal synergistic therapy, with an emphasis on the structural and biological aspects of these studies. |
| first_indexed | 2024-04-11T06:46:40Z |
| format | Article |
| id | doaj.art-3058199804194eebb2d4c6e8b96080e0 |
| institution | Directory Open Access Journal |
| issn | 0753-3322 |
| language | English |
| last_indexed | 2024-04-11T06:46:40Z |
| publishDate | 2022-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Biomedicine & Pharmacotherapy |
| spelling | doaj.art-3058199804194eebb2d4c6e8b96080e02022-12-22T04:39:20ZengElsevierBiomedicine & Pharmacotherapy0753-33222022-12-01156113872Recent advances in gene therapy-based cancer monotherapy and synergistic bimodal therapy using upconversion nanoparticles: Structural and biological aspectsMarzieh Sohrabi0Zahra Babaei1Vahid Haghpanah2Bagher Larijani3Ali Abbasi4Mohammad Mahdavi5Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, IranEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, IranEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, IranEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, IranCorresponding authors.; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, IranCorresponding authors.; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, IranIn accordance with human genetics and genomics advances over the past years, it can be found that cancer is created through a somatic aberration in the host genome. Accordingly, researchers use therapeutic methods in genetic manipulation to discover the possible cure for the disease. In combination with traditional cancer treatments, gene therapy (GT) is essential in future cancer therapy. The development of powerful nanocarriers for targeted, controlled, and efficient intracellular delivery of therapeutic biomolecules that increase pharmacokinetics indicates that the development of GT is highly dependent on nanotechnology. Among nanocarriers, upconversion nanoparticles (UCNPs) have become the focus of great attention in the realm of inorganic nanomedicines following the strategy of ''diagnosis for treatment'' due to their outstanding features including safety, deep penetration of near-infrared (NIR) light into tissue, and reduction of unfavorable side effects of NIR-triggered therapies. Moreover, various individual therapies can be intelligently combined into a single nanotranostic system based on a UCNP platform for multimodal synergistic treatment. Given that the preparation of multifunctional nanomaterials is a prerequisite for the realization of cancer treatment, especially synergistic therapies, the recognition of the main components of advanced nanoparticles can help researchers in choosing the proper platform for cancer treatment. In view of this, the main goal of this review is to highlight the latest advances in the construction and application of upconversion nanoparticles as carriers for gene delivery and gene editing in cancer monotherapy and bimodal synergistic therapy, with an emphasis on the structural and biological aspects of these studies.http://www.sciencedirect.com/science/article/pii/S0753332222012616Upconversion nanoparticlesGene therapySiRNAPDNACRISPR-Cas9Bimodal synergistic therapy |
| spellingShingle | Marzieh Sohrabi Zahra Babaei Vahid Haghpanah Bagher Larijani Ali Abbasi Mohammad Mahdavi Recent advances in gene therapy-based cancer monotherapy and synergistic bimodal therapy using upconversion nanoparticles: Structural and biological aspects Biomedicine & Pharmacotherapy Upconversion nanoparticles Gene therapy SiRNA PDNA CRISPR-Cas9 Bimodal synergistic therapy |
| title | Recent advances in gene therapy-based cancer monotherapy and synergistic bimodal therapy using upconversion nanoparticles: Structural and biological aspects |
| title_full | Recent advances in gene therapy-based cancer monotherapy and synergistic bimodal therapy using upconversion nanoparticles: Structural and biological aspects |
| title_fullStr | Recent advances in gene therapy-based cancer monotherapy and synergistic bimodal therapy using upconversion nanoparticles: Structural and biological aspects |
| title_full_unstemmed | Recent advances in gene therapy-based cancer monotherapy and synergistic bimodal therapy using upconversion nanoparticles: Structural and biological aspects |
| title_short | Recent advances in gene therapy-based cancer monotherapy and synergistic bimodal therapy using upconversion nanoparticles: Structural and biological aspects |
| title_sort | recent advances in gene therapy based cancer monotherapy and synergistic bimodal therapy using upconversion nanoparticles structural and biological aspects |
| topic | Upconversion nanoparticles Gene therapy SiRNA PDNA CRISPR-Cas9 Bimodal synergistic therapy |
| url | http://www.sciencedirect.com/science/article/pii/S0753332222012616 |
| work_keys_str_mv | AT marziehsohrabi recentadvancesingenetherapybasedcancermonotherapyandsynergisticbimodaltherapyusingupconversionnanoparticlesstructuralandbiologicalaspects AT zahrababaei recentadvancesingenetherapybasedcancermonotherapyandsynergisticbimodaltherapyusingupconversionnanoparticlesstructuralandbiologicalaspects AT vahidhaghpanah recentadvancesingenetherapybasedcancermonotherapyandsynergisticbimodaltherapyusingupconversionnanoparticlesstructuralandbiologicalaspects AT bagherlarijani recentadvancesingenetherapybasedcancermonotherapyandsynergisticbimodaltherapyusingupconversionnanoparticlesstructuralandbiologicalaspects AT aliabbasi recentadvancesingenetherapybasedcancermonotherapyandsynergisticbimodaltherapyusingupconversionnanoparticlesstructuralandbiologicalaspects AT mohammadmahdavi recentadvancesingenetherapybasedcancermonotherapyandsynergisticbimodaltherapyusingupconversionnanoparticlesstructuralandbiologicalaspects |